2009 IoN News Archive
- Grant for research into new epilepsy treatments
- Professor Martin Rossor has been recognised by the The Alzheimer's Association
- Drug discovery collaboration on inclusion body myositis
- PDS awards Training Fellowship to Institute of Neurology researcher to understand how the brain controls Parkinson’s symptoms
- Alan Thompson to lead UCL Partners Neurological Disorders theme
- World MS Day - Wednesday 27th May - Global initiative to highlight Multiple Sclerosis
- Queen Square leads on new UK recommendations for bladder management which can dramatically improve quality of life in Multiple Sclerosis
- John Hardy most-cited Alzheimer's disease researcher in the UK
- Prestigious awards for Institute researchers
- Drug study offers hope for Alzheimer’s treatment
- Brain activity predicts our choices
- Professor George du Boulay CBE, FRCR, FRCP
- Brain awareness week: the impact of UCL research
- Parkinson's-linked mutation makes neurons vulnerable to calcium-induced death
- Second round of NIHR Senior Investigators announced
- 'Mind-Reading' Experiment Highlights How Brain Records Memories
- Anti-malaria drug does not appear to help with human prion diseases.
- UCL Partners is one of UK’s first Academic Health Science Centres
- "Opening doors for patients with MS"
- Are we as decisive as we think?
- "Magnets stop the nightmare of tinnitus, researchers say."
- Prestigious award for Professor Hugh Bostock
- Untangling the Brain
- Young UCL Investigator Award in neuroimaging techniques
- Brain disease "resistance gene" could offer insights into CJD
- Neurology: A Queen Square Textbook
- Headache: annual evidence update
- Roads closed for powerful MRI scanner delivery
- Long-term risks lower for surgical treatment of carotid stenosis
- Memorandum of collaboration signed
- Professor John Hardy joins the ranks of science greats
- Drug study offers hope for Alzheimer's treatment
- Prestigious award for Professor David Miller
- Magnets stop the nightmare of tinnitus, researchers say.
- Brain activity predicts our choices
- Jon Driver Award
- Professor Sander named recipient of the American Epilepsy Society 2009 Clinical Science Award
- Study highlights effect of brain waves on human behaviour
- New podcast describes the significance and impact of highly cited paper
- NIH Grant for research into inherited neuropathies
- How the brain knows a dog is a dog: concept acquisition in the human brain
- Prof Elizabeth Fisher elected member of the European Molecular Biology Organization (EMBO)
- Locating literacy in the brain
- Dopamine enhances expectation of pleasure in humans
- Queen Square scientists question memory theory
- IoN scientist to front Alzheimer’s Research Trust national appeal
- New doors open to the understanding of the origin of brain tumours
Published: Mar 6, 2014 10:56:13 AM
Published: Feb 14, 2014 4:38:40 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Sep 16, 2013 1:37:21 PM
Published: Sep 20, 2013 12:43:48 PM
Published: Feb 20, 2014 6:58:34 PM
Published: May 11, 2013 3:39:00 PM
Published: Jan 16, 2014 12:32:49 PM
Long-term risks lower for surgical treatment of carotid stenosis
29 August 2009
The latest results from the longest-running study yet confirm that surgery is better than artery-opening angioplasty in preventing strokes caused by blockage of the carotid artery, the largest vessel carrying blood to the brain.
"In contrast with endovascular treatment [angioplasty], surgical patients had about half the rate of strokes in long-term follow-up," said Professor Martin M. Brown, Department of Brain Repair & Rehabilitation, consultant at the National Hospital for Neurology & Neurosurgery, and a senior author of two reports in the October issue of the Lancet Neurology.
Brown is a leader of the CAVATAS study, which has followed 504 people with carotid artery stenosis (narrowing) who were randomly assigned to have either the surgical procedure called endarterectomy or angioplasty.
"This was the first trial ever started comparing endovascular treatment with surgery," Brown said. Some participants in the trial have been followed for as long as eight years.
The second study reported on 413 CAVATAS participants who had periodic ultrasound examinations of the treated carotid arteries over the following five years. The study found that the incidence of severe re-narrowing of the carotid artery was much higher in the angioplasty group. (text adapted from US News & World Report)
references>> The Lancet Neurology, Early Online Publication, 29 August 2009doi:10.1016/S1474-4422(09)70227-3
Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Leo H Bonati, Jörg Ederle, Dominick JH McCabe et al
The Lancet Neurology, Early Online Publication, 29 August 2009doi:10.1016/S1474-4422(09)70228-5
Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Jörg Ederle, Leo H Bonati, Joanna Dobson et al
Page last modified on 24 sep 09 13:42